Revolution Medicines, Inc. number of employees

Revolution Medicines, Inc. reported 883 employees at December 31, 2025 in its latest annual report, up 349 (65.4%) on the year before. That compares with 188 at December 31, 2021.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	883	+349 (65.4%)	—	10-K, filed February 25, 2026
December 31, 2024	534	+156 (41.3%)	—	10-K, filed February 26, 2025
December 31, 2023	378	+132 (53.7%)	$30,635	10-K, filed February 26, 2024
December 31, 2022	246	+58 (30.9%)	$143,821	10-K, filed February 27, 2023
December 31, 2021	188	—	$156,330	10-K, filed February 28, 2022

What the annual reports say

Employees and Human Capital Resources As of December 31, 2025, we had 883 full-time employees. 2025 annual report
Employees and Human Capital Resources As of December 31, 2024, we had 534 full-time employees. 2024 annual report
Employees and Human Capital Resources As of December 31, 2023, we had 378 full-time employees, including 145 employees who have M.D. or Ph.D. degrees. 2023 annual report
Employees and human capital resources As of December 31, 2022, we had 246 full-time employees, including 105 employees who have M.D. or Ph.D. degrees. 2022 annual report
Employees and human capital resources As of December 31, 2021, we had 188 full-time employees, including 82 employees who have M.D. or Ph.D. degrees. 2021 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Revolution Medicines, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Revolution Medicines, Inc.